{"filing":{"accession_number":"0001477932-26-005805","cik":"0001187953","ticker":"CELZ","company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","form":"8-K","filing_date":"2026-09-25","report_date":"2026-09-24","primary_document":"celz_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1187953/000147793226005805/celz_8k.htm"},"events":[{"id":35197,"run_id":32409,"accession_number":"0001477932-26-005805","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"Creative Medical Technology Holdings, Inc. entered into a Stock Purchase Agreement to acquire 4,000,000 shares of BioDefense, Inc., resulting in 80% ownership. The transaction consideration consists of $200,000 cash plus 1,000,000 shares of Company stock, representing a significant capital deployment and change in the Company's ownership structure.","company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","filing_date":"2026-09-25","form":"8-K","submitted_at":null,"items":[{"id":39161,"accession_number":"0001477932-26-005805","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The Company entered into a Stock Purchase Agreement to acquire 4,000,000 shares of BioDefense, Inc., resulting in 80% ownership of BioDefense. This constitutes a material acquisition under Item 1.01, as the transaction involves a significant equity stake in another company and is structured as a definitive agreement with substantial consideration ($200,000 cash plus 1,000,000 shares of Company stock). The transaction is material to investors as it represents a significant capital deployment and change in the Company's ownership structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T21:02:16.563797+00:00","company_name":"","ticker":null,"filing_date":""},{"id":39162,"accession_number":"0001477932-26-005805","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 discloses an unregistered sale of equity securities by Creative Medical Technology Holdings, Inc., with the substantive details incorporated by reference from Item 1.01. Unregistered equity issuances are material events that dilute existing shareholders and typically signal capital-raising activity, particularly common at smaller-cap issuers. The reference to Item 1.01 suggests this is part of a broader transaction disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T21:02:16.563797+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":39161,"accession_number":"0001477932-26-005805","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The Company entered into a Stock Purchase Agreement to acquire 4,000,000 shares of BioDefense, Inc., resulting in 80% ownership of BioDefense. This constitutes a material acquisition under Item 1.01, as the transaction involves a significant equity stake in another company and is structured as a definitive agreement with substantial consideration ($200,000 cash plus 1,000,000 shares of Company stock). The transaction is material to investors as it represents a significant capital deployment and change in the Company's ownership structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T21:02:16.563797+00:00","company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","filing_date":"2026-09-25"},{"id":39162,"accession_number":"0001477932-26-005805","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 discloses an unregistered sale of equity securities by Creative Medical Technology Holdings, Inc., with the substantive details incorporated by reference from Item 1.01. Unregistered equity issuances are material events that dilute existing shareholders and typically signal capital-raising activity, particularly common at smaller-cap issuers. The reference to Item 1.01 suggests this is part of a broader transaction disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T21:02:16.563797+00:00","company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","filing_date":"2026-09-25"}]}